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Abstract 
The importance of the Cucurbitaceae family consists not only in the species that are widely known for various economically 
important human uses, but also in the species that have proven an important and promising potential concerning their 
biological activities. Bryonia alba L. and Ecballium elaterium (L.) A. Rich. are two species belonging to this family, that are 
known since ancient times for their homeopathic or traditional use in the treatment of numerous disorders. There is clear 
evidence that links between the two species are not only related to family morphological characters, but also to a certain 
degree to the sexual system and, most importantly, to the active principle content or to potential medicinal uses. All these 
elements helped to include both species in the same tribe and may result in important reasons for heading future studies 
towards the elucidation of their complete phytochemical composition and mechanisms of the biological activities. The 
present study aims to review the existing scientific literature on the two species and to offer sufficient evidence in order to 
justify a most detailed study of their pharmaceutical potential. 
 
Rezumat 
Importanţa familiei Cucurbitaceae constă nu numai în specii care sunt cunoscute în sens larg pentru utilizările economice, 
dar şi în specii care şi-au demonstrat un potenţial important şi promiţător ca specii cu activitate biologică. Bryonia alba L. şi 
Ecballium elaterium (L.) A. Rich. sunt două specii aparţinând familiei Cucurbitaceae care sunt cunoscute din cele mai vechi 
timpuri pentru utilizările în homeopatie sau în medicina tradiţională pentru tratamentul a numeroase afecţiuni. Există dovezi 
ştiinţifice clare pentru legăturile dintre cele două specii, care se referă nu numai la caracterele morfologice specifice familiei, 
dar de asemenea într-o anumită măsură şi la sistemul sexual şi, cel mai important, la conţinutul în principii active sau la 
potenţialele utilizări medicinale. Toate acestea au favorizat includerea ambelor specii în acelaşi trib şi reprezintă dovezi 
importante pentru îndreptarea ulterioară a studiilor spre elucidarea completă a compoziţiei fitochimice şi a mecanismelor 
implicate în activitatea biologică. Studiul de faţă îşi propune aşadar să ofere o trecere în revistă a dovezilor ştiinţifice 
existente în literatura de specialitate legate de cele două specii şi să ofere argumente suficiente pentru a justifica un viitor 
studiu amănunţit al potenţialului lor farmaceutic. 
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Introduction 
The Cucurbitaceae family (Cucurbitales order) is 
one of the most important families known 
worldwide [41], especially for the species that have 
economically important uses in many fields, among 
which food, agriculture or cosmetic industries are 
the most frequently known [65]. The family 
comprises 90 genera, with approximately 700 
species, which grow especially in the tropical 
regions [41]. Species as Citrullus lanatus (Thunb.) 
Mansf., Cucurbita pepo L. and  Luffa cylindrica L. 
are the most popular species of the family [47, 91, 
97] and are known for their importance in 
alimentation [3] or in different other industries [65, 
91, 97]. However, some plants belonging to this 
family have proved to be potentially medicinally 
valuable, not only for their content in nutrients, but 
also because of their content in active principles, as 
for example cucurbitacins, which are the most 
important compounds found in the composition of 
these plants [41]. 
Cucurbitacins are highly oxygenated compounds, 
belonging to the class of tetracyclic triterpenoids [7, 
26, 33, 51, 60, 76]. Currently, there are 12 classes 
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of cucurbitacins known, which contain the 16 
cucurbitacins (A-S), grouped according to their 
different molecular variations (Figure 1) [76]. Out 
of these aglycones, hundreds of derivatives have 
been discovered. Structurally, cucurbitacins are 
derivatives of the tetracyclic nucleus skeleton 
cucurbita-5-ene (IUPAC name: 19-(10→9-β)-abeo-
5 alpha- lanostane), also known as 9-β-methyl-19-
nor-lanosta-5-ene, which can be modified by 
oxygen-containing groups and by double bonds to 
produce the 16 cucurbitacins known [7, 51]. Most 
of the cucurbitacins are found as glycosides, having 
the glycosidic part linked to the carbon found in the 
position number 2 (2-O-β-glycosides) [7]. 
 
Figure 1. 
General structure of the cucurbita-5-ene, basic 
structure of cucurbitacins
 
Table I 
Structure of the cucurbitacins [7, 51] 
Compound 
Modification of the basic structure 
1-2 2 3 11 16 19 20 22 23-24 24 25 
Cucurbitacin A - -OH =O =O -OH -OH -OH =O = - -OAc 
Cucurbitacin B - -OH =O =O -OH - -OH =O = - -OAc 
Cucurbitacin C - - -OH =O -OH -OH -OH =O = - -OAc 
Cucurbitacin D - -OH =O =O -OH - -OH =O = - -OH 
Cucurbitacin E = -OH =O =O -OH - -OH =O = - -OAc 
Cucurbitacin F - -OH -OH =O -OH - -OH =O = - -OH 
Cucurbitacin G = 
Cucurbitacin H 
- -OH =O =O -OH - -OH =O - -OH -OH 
Cucurbitacin I = -OH =O =O -OH - -OH =O = - -OH 
Cucurbitacin J = -OH =O =O -OH - -OH =O - -OH -OH 
Cucurbitacin K = -OH =O =O -OH - -OH =O - -OH -OH 
Cucurbitacin L = -OH =O =O -OH - -OH =O - - -OH 
Cucurbitacin O - -OH -OH =O -OH - -OH =O = - -OH 
Cucurbitacin P - -OH -OH =O -OH - -OH =O - - -OH 
Cucurbitacin Q - -OH -OH =O -OH - -OH =O = - -OAc 
Cucurbitacin R - -OH =O =O -OH - -OH =O - - -OH 
Cucurbitacin S = -OH =O =O 
 
 
Although plants belonging to Cucurbitaceae family 
that contain cucurbitacins are mostly known for 
their toxicity [51, 60], they are also studied for their 
large number of potential pharmacological activities 
[33, 51]. Among these, the most known and considered 
by the scientific literature are the antioxidant, anti-
inflammatory [26], antidiabetic and antiathero-
sclerotic activities [60], but particularly the 
cytotoxic and anticancer ones [7, 33, 76]. In the last 
years, plants belonging to Cucurbitaceae family have 
experienced an important increase in the attention 
of many researchers, due to their important content 
in active principles that have proved significant 
biological activities and important potential for 
their introduction in the therapy of numerous 
pathologies [60]. 
Bryonia alba L. and Ecballium elaterium (L.) A. 
Rich. are two species of the Cucurbitaceae family 
that have proven important potential as medicinal 
plants [115]. Phylogenetic studies [65, 102] cite a 
link between the two species and therefore Bryonia 
alba L. appears to be the elder sister of Ecballium 
elaterium (L.) A. Rich. [102]. The similarities 
between the two species include morphological 
characters and help the inclusion of both species in 
the Bryonieae tribe [65, 102]. The two species are 
included in the genera that present few differences 
that are mostly related to the sexual system [102]. 
The shifts that are related to monoecy and dioecy 
occur in the same genera, as in the case of Bryonia, 
or, as in the case of Ecballium, in the same species 
[114]. Actually, the differences between the two 
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species are not significant and despite them, there 
are phylogenetic studies that cite the close 
relationship between the two species [65, 102, 103, 
114, 116], which were also the main reasons for 
their inclusion in the same tribe, together with an 
Australian endemic genus, Austrobryonia [103]. 
The present bibliographical study is an overview of 
the existing data in the scientific literature that aims 
to bring out the important pharmaceutical potential 
of these two related species that may provide potent 
compounds for the treatment of various diseases. 
Bryonia alba L. 
Bryonia genus, with 10 species [102], comprises 
monoecious or dioecious, perennial, herbaceous 
and climbing species, with simple leaves, simple 
tendrils and small greenish-yellow flowers, 5 
stamens, grouped in 3 bundles, 3-lodged globular 
ovary and a black globular glabrous small-sized 
indehiscent berry as a fruit [115]. 
 
 
Figure 2. 
Left - Spontaneous Bryonia alba L. in Cluj-Napoca 
county (North Western Transilvania, Romania); 
Right – Macroscopic characters of the B. alba species 
 
Bryonia alba L. is a monoecious species, which 
grows especially in dried soils, preferring rocky 
slopes in the mountainous areas, dry riverbeds or 
even sand dunes. Special adaptations help it to 
resist to external conditions. It has large tubers, 
which help storing the water underground [115]. 
Phylogeographic studies cite its presence in the 
Central European region, with some extensions in 
Northern, Eastern and Southern parts, reaching 
even to Kazakhstan, North Africa, Canary Islands 
or Central Asia [102, 114, 115]. Studies performed 
by Volz and Renner in 2009 state that there is a 
high possibility that it is the only Bryonia species 
found in Romania, as the presence of Bryonia 
dioica Jacq. remains uncertain [115]. 
 
 
Figure 3. 
Geographic distribution of the B. alba L. species, as 
described by Volz and Renner (2009) [115] 
 
The species is mostly known for its homeopathic 
uses. The root is used in homeopathic preparations 
to induce dryness of the mucous membranes [35], 
for laxative and purgative effects [115] and for its 
antiinflammatory effect in the inflammation of the 
serous tissues or for the treatment of cough, 
pneumonia and rheumatism [78]. It is a species that 
has also proven its importance in traditional 
medicine, particularly as purgative, mostly due to 
its content of cucurbitacins [22, 66, 67, 85, 88, 92]. 
Besides cucurbitacins, which are the most 
important compounds found in the composition of 
the species, there are also other compounds, which 
can increase or can act synergistically with them for 
increasing the biological activity [53]. Table II 
contains the most important compounds that are 
found in the composition of B. alba. 
Table II 
The most important active principles found in the composition of the B. alba species 
Compounds Part of the species Reference(s) 
Cucurbitacins Root  [22, 66, 67, 85, 88, 92] 
Flavonoids Aerial part [69, 70] 
Sterols Roots [87] 
Lectins Roots [48] 
Amino-acids Roots  [59] 
Trihydroxyoctadecadienoic acids Roots  [58, 84] 
Lipids  Roots [89] 
 
The compounds found in different parts of B. alba 
give an important potential for its use as therapeutic 
or adjuvant treatment. The most important activity 
is due to the high content of cucurbitacins in the 
roots. Because of this reason, this part of the 
species is the most studied [22, 48, 58, 59, 66, 67, 
87]. Cucurbitacins, especially cucurbitacins B, D, 
E, I and their derivatives, but also cucurbitacins J, 
K, L are found in important amounts in the roots 
[22, 66, 67] and provide cytotoxic effects [22] or 
even antitumor activities. The most cytotoxic 
cucurbitacins seem to be cucurbitacin B, D, E and I, 
but the others present nevertheless moderate 
activities [66]. There is also evidence of the fact 
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that roots of B. alba, containing trihydroxy-
octadecadienoic acids (class of trihydroxy fatty 
acids), can exhibit hypoglycaemic activity [108] or 
can even correct major abnormalities typical in 
severe diabetes mellitus [58]. Other studies state 
that the same compounds may exhibit preventive 
atherogenic or antiatherosclerotic activities [84]. At 
the same time, in the context of the protective 
activities for biological systems, there are studies 
that prove the hepatoprotective activity of the roots 
extract [78] or even the protective activity for 
human cells against endogenous oxidative DNA 
damage, although the ability of protection towards 
the exogenous oxidative DNA damage could not be 
demonstrated [81]. 
B. alba roots are also widely known for their 
adaptogen activity, which some sources associate to 
the content of cucurbitacins (especially cucurbitacin 
R diglucoside), which enhance the sensitivity level 
to stress, due to the effects of eicosanoids and 
corticosteroids [85]. Actually, B. alba roots can 
also increase nitric oxide (NO) in humans [86], 
which can be responsible for the adaptation of the 
human organism to heavy physical exercise. On the 
contrary, the same NO molecule, which is 
responsible for numerous inflammatory processes 
[34], is inhibited by B. alba roots in its formation 
process, by inhibition of the activity of its inducible 
enzyme, iNOS (inducible NO synthase), which can 
be a possible mechanism of action for the anti-
inflammatory effect [92]. 
All of these findings represent important arguments 
for the promising phytopharmacological potential 
of B. alba species. At the same time, they are 
supplementary reasons for a future most detailed 
investigation, as many details remain to be clarified 
about the subject. 
Ecballium elaterium (L.) A. Rich. 
Ecballium genus comprises only one species, which 
is an annual herb, with no tendrils, small yellow 
flowers, 5 stamens, grouped by 2 and the fifth being 
free, a medium-sized oblong hairy berry, watery 
and ejecting seeds by elastic contraction [4, 20, 32, 
52]. This single species is divided in 2 subspecies, 
with different breeding systems: subspecies dioicum, 
which is dioecious and subspecies elaterium, which 
is monoecious. This intraspecific variation provides 
a unique opportunity to study the influence of the 
sexual system on the genetic consequences [36]. 
It grows mostly on disturbed ground from Northern 
Spain, through Southern Europe to the Mediterranean, 
North Africa and Southwest Asia [36, 102]. Because 
of its habitat, it has developed important 
morphological and anatomical features, mostly 
related to the structure of the leaf, that help it to 
withstand the stressful external conditions [32]. 
 
 
 
Figure 4. 
Left - Spontaneous Ecballium elaterium  (L.) A. 
Rich. in Constanţa county (South Eastern 
Dobrogea, Romania); Right – Macroscopic 
characters of the E. elaterium  species 
 
 
Figure 5. 
Geographic distribution of the Ecballium elaterium 
(L.) A. Rich. species, as described by Costich and 
Meagher (1992): in light red distribution of Ecballium 
elaterium ssp. elaterium and in dark red distribution 
of Ecballium elaterium ssp. dioicum [36] 
 
As in the case of its older relative, E. elaterium is 
mostly known for its important content of 
cucurbitacins [19], which can provide the species 
with various biological activities. Actually, the first 
known cucurbitacin, elaterin (cucurbitacin E) was 
isolated for the first time from the fruit juice of E. 
elaterium [52]. Because of this reason, the species 
is considered to be an important “indicator plant” 
among the species with high content of 
cucurbitacins [19]. The highest concentration of 
cucurbitacins was found in fruits, followed by 
stems and leaves [18]. Besides cucurbitacins, the 
species contains other important compounds, which 
can enhance its biological activities [20]. Table III 
summarizes some of these compounds. 
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Table III 
The most important active principles found in the composition of the E. elaterium species 
Compounds Part of the species Reference(s) 
Cucurbitacins Roots, leaves, stems, flowers, fruits and seeds 
[10, 19, 30, 52, 73, 74, 88, 
98, 104-106] 
Flavonoids and phenolic compounds Leaves, stems, flowers, fruits and seeds [10, 55, 56, 95, 110] 
Sterols Roots, leaves, stems, flowers, fruits and seeds [10, 54, 74, 111] 
Fatty acids, lipids and oils Roots, leaves, stems, flowers, fruits and seeds [10, 30, 54, 74] 
Essential oils Leaves, fruits and seeds [46, 96] 
Carotenoids Roots, leaves, stems, flowers, fruits and seeds [10] 
Soluble sugars (e.g. sucrose, raffinose) Leaves  [6, 10, 30] 
Trypsin inhibitors Seeds  [13] 
Tannins  Leaves, flowers [10] 
Alkaloids  Roots, leaves, stems, flowers, fruits and seeds [10] 
Amino-acids and amino-acis decarboxylases  Seeds  [37, 43] 
 
Several biological activities of the species, as anti-
microbial [1, 4, 25, 82], anti-inflammatory [90, 107, 
112], antioxidant [101] or cytotoxic [14, 15, 17, 28, 
74, 98, 101, 111] are the most frequently described 
in the scientific literature. Studies of the undiluted 
fruit juice state that there is an important cytotoxic 
and genotoxic effect on Allium cepa root tip cells 
[30]. The main responsible molecules for these 
activities seem to be again the cucurbitacins and 
most specific cucurbitacin E, which is mostly 
known to provide the cytotoxic activity [15, 17, 28, 
98]. Cucurbitacin E is not studied only for its 
cytotoxic effect, but also for its ability to stimulate 
the immune system [14, 16], which can be vital for 
the possible anti-cancer activity. At the same time, 
it seems to have minor cytotoxic effects on normal 
cell lines [17]. Not only cucurbitacin E is present in 
the composition of different part of the species, but 
also other compounds, as for example cucurbitacin 
B, D or I [21, 109]. There are a lot of studies that aim 
to develop specific methods in order to increase the 
concentration of these compounds [109]. 
There are also many other activities that E. 
elaterium species is responsible for. Traditional 
medicine describes mostly the use of the fruit juice 
as nasal drops for the treatment of jaundice in new-
borns [2, 9, 80]. Despite of this fact, there are 
studies that consider it as a highly toxic plant, 
especially for its juice, which exhibits its toxic 
activity on the respiratory, cardiac and gastric 
systems, but also for the mucous membranes it 
takes contact with [8, 12, 20, 27, 29, 30, 44, 64, 77, 
90, 94, 99, 100, 113]. There are studies which state 
that the administration of the juice to rats with 
surgically induced jaundice produced a decrease in 
serum bilirubin concentration, which apparently is due 
to its content of cucurbitacin B, D and E and may 
increase the binding of domain specific ligands, 
ibuprofen and bilirubin [49, 50]. 
The species is also traditionally used as a treatment 
for otitis, sinusitis, malarial fever, headaches or 
sinusitis and rheumatism [20, 30, 42, 71]. Studies 
performed by Agil et al. [5] and by El Naggar et al. 
[45] suggested a hepatoprotective activity against 
induced hepatotoxicity in rats. Another study, 
performed by Dubeau and his co-workers state the 
neuroprotective activity of cucurbitacin E, isolated 
from E. elaterium [11]. It may also have beneficial 
effects on sepsis-induced lung injury, which is 
demonstrated by the research team of Demir in rats 
[40]. Protective activity of E. elaterium may be due 
to its ability to reduce abdominal adhesion and may be 
a useful tool for the antiinflammatory activity in the 
prevention of postoperative peritoneal adhesion [83]. 
A lot of studies aim to investigate the anti-trypsin 
activity of E. elaterium. Seeds of the species 
contain a specific polypeptide, actually a protease 
inhibitor, which specifically acts against trypsin, 
being one of the most potent trypsin inhibitor [20]. 
It may also represent an important target for the 
isolation of small peptide molecules that have 
affinity for acceptor molecules [31]. The EETI-II 
(Ecballium elaterium trypsin inhibitor) has a rigid 
molecular scaffold [68] and a structure that can be 
mutated in its loops in order to bind with high 
affinity to integrin receptor associated in tumours 
and a radiolabelled version of this knotting peptide 
can help to develop the non-invasive imaging of 
integrin expression in humans [61, 63, 72, 79]. This 
type of molecule represents a target for protein 
engineering that can also be useful in cancer 
therapy [62] or can represent the basis of the 
synthesis of modified derivatives with potent 
inhibitory activity towards pancreatic elastase, 
chymotrypsin and human leucocyte elastase [75]. 
Cucurbitacins that are present in the composition of 
the species (mostly cucurbitacin D and cucurbitacin 
I) may perform an important role in the defence 
mechanisms of the plants, as suggested by Bar-Nun 
et al. in 1989 and 1990, when the activity against 
Botrytis cinerea Pers., due to the inhibition of 
laccase formation, was demonstrated [23, 24]. In 
1999, Villalobos and co-workers demonstrated that 
leaves extract of E. elaterium can exhibit a potent 
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anti-insect activity, which can be the result of the 
internal defence mechanisms of the plant [93]. This 
is also the main reason for the possibility of using 
the extracts of the plant to inhibit the germination 
of growth of some other plant species [96]. 
However, essential oils obtained from the species 
could also play a role in the allelopathic effect [57]. 
In the context of improving the methods of crop 
maintenance, this appears as an innovative technique, 
beside methods that already imply growing patterns 
[39] in order to diminuate the quantity of unwanted 
compounds, especially in foods [38].  
All of these emphasize the reasons to carry on the 
investigations on the important therapeutically 
potential of the E. elaterium, but also give 
arguments for a more detailed investigation on the 
species, as there are a lot of unclear aspects, that 
need further evidence in order to establish the real 
pharmaceutical potential of E. elaterium. 
 
Conclusions 
Bryonia alba L. and Ecballium elaterium (L.) A. Rich. 
are two species belonging to the Cucurbitaceae 
family, that are related from many points of view. 
Similarities are related to morphological characters 
(e.g. root or leaf morphology), in part to the sexual 
system (e.g B. alba is monoecious and E. elaterium 
can be both monoecious and dioecious), but also to 
the content of active compounds (e.g. cucurbitacins, 
flavonoids, sterols, lipids) and to their biological 
activities (e.g. cytotoxic, antiinflammatory, hepato-
protective). There are also some differences 
between the two species, which are concerning the 
same points of view: morphological characters (e.g. 
flowers, fruits morphology), sexual system  (e.g B. 
alba is only monoecious and E. elaterium can be 
both monoecious and dioecious), active compounds 
content (e.g. trihydroxyoctadecadienoic acids for B. 
alba and trypsin inhibitors for E. elaterium) or 
biological activities (e.g. antidiabetic and anti-
atherosclerotic for B.alba and anti-trypsin for E. 
elaterium). Nevertheless, phylogenetic studies have 
confirmed the link between the species and helped 
including both in the same tribe (Bryonieae) of the 
family Cucurbitaceae. There are also many data 
that prove their important potential as medicinal 
plants. Despite the existence of many studies that 
aim to establish links between the content of active 
compounds and the biological activities, there are 
yet a lot of unknown or unclear aspects, which 
however have the necessary background to be 
clarified. This is the reason why the present study 
aimed to bring into attention the most important 
points related to the two species and offer the 
necessary arguments for a future most detailed 
study of the two species. It is important to clarify 
the aspects related to the biological activities of the 
two plants in order to state their use in the treatment 
of different disorders. As Bryonia alba L. and 
Ecballium elaterium (L.) A. Rich. offer promising 
pharmaceutical potential, it is essential to further 
investigate and clarify all the aspects which are 
related to it. 
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